Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIG1 hypoxia inducible domain family member 1A pseudogene 9 (HIGD1AP9) is annotated as a human pseudogene, meaning it is a DNA sequence similar to the functional HIGD1A gene but is generally not transcribed or translated into a functional protein product. Pseudogenes such as HIGD1AP9 are not considered therapeutic targets, and there are no known biological functions, disease associations, or drug interactions. The related protein-coding gene, HIGD1A, encodes a mitochondrial protein involved in cellular survival under hypoxia, but HIGD1AP9 does not share this role. In summary, HIGD1AP9 is a pseudogene, not a molecular target for drug discovery or therapeutic intervention.
None (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene 9 (HIGD1AP9).